Literature DB >> 29793345

Dignity Impact as a Primary Outcome Measure for Dignity Therapy.

Lisa Scarton1, Sungho Oh1, Ashley Sylvera1, Ralph Lamonge1, Yingwei Yao1, Harvey Chochinov2,3, George Fitchett4, George Handzo5, Linda Emanuel6, Diana Wilkie1.   

Abstract

BACKGROUND: Feasibility of dignity therapy (DT) is well established in palliative care. Evidence of its efficacy, however, has been inconsistent and may stem from DT's primary effects differing from the outcomes measured in previous studies. We proposed that DT effects were in the spiritual domain and created a new outcome measure, Dignity Impact Scale (DIS), from items previously used in a large randomized controlled trial (RCT).
OBJECTIVE: The purpose of this secondary analysis study was to examine properties of a new measure of dignity impact.
DESIGN: Using the DIS, we conducted reanalysis of posttest data from a large 3-arm, multi-site RCT study. SETTING/PARTICIPANTS: Participants were receiving hospice/palliative care (n = 326, 50.6% female, mean age = 65.1 years, 89.3% white, all with a terminal illness with 6 months or less life expectancy). They had been randomized to standard palliative care (n = 111), client-centered care (n = 107), or DT (n = 108). MEASUREMENT: The 7-item DIS was derived from selected items in a posttest DT Patient Feedback Questionnaire. The DIS had strong internal consistency (α = 0.85).
RESULTS: The DT group mean DIS score (21.4 ± 5.0) was significantly higher than the usual care group mean score (17.7 ± 5.5; t = 5.2, df = 216, P < .001) and a client-centered intervention group mean score (17.9 ± 4.9; t = 5.2, df = 213, P < .001).
CONCLUSION: We found that, compared to both other groups, patients who received DT reported significantly higher DIS ratings, which is consistent with the DT focus on meaning-making, preparation for death, and life completion tasks. We propose that the DIS be used as the primary outcome measure in evaluating the effects of DT.

Entities:  

Keywords:  dignity impact; dignity therapy; measure; outcome; psychosocial; spiritual

Mesh:

Year:  2018        PMID: 29793345      PMCID: PMC6082719          DOI: 10.1177/1049909118777987

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.090


  18 in total

1.  Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life.

Authors:  Harvey Max Chochinov; Thomas Hack; Thomas Hassard; Linda J Kristjanson; Susan McClement; Mike Harlos
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

Review 2.  Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference.

Authors:  Christina Puchalski; Betty Ferrell; Rose Virani; Shirley Otis-Green; Pamela Baird; Janet Bull; Harvey Chochinov; George Handzo; Holly Nelson-Becker; Maryjo Prince-Paul; Karen Pugliese; Daniel Sulmasy
Journal:  J Palliat Med       Date:  2009-10       Impact factor: 2.947

3.  Dignity in the terminally ill: a developing empirical model.

Authors:  Harvey Max Chochinov; Thomas Hack; Susan McClement; Linda Kristjanson; Mike Harlos
Journal:  Soc Sci Med       Date:  2002-02       Impact factor: 4.634

4.  Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial.

Authors:  Harvey Max Chochinov; Linda J Kristjanson; William Breitbart; Susan McClement; Thomas F Hack; Tom Hassard; Mike Harlos
Journal:  Lancet Oncol       Date:  2011-07-06       Impact factor: 41.316

5.  A prospective evaluation of Dignity Therapy in advanced cancer patients admitted to palliative care.

Authors:  Lise J Houmann; Harvey M Chochinov; Linda J Kristjanson; Morten Aa Petersen; Mogens Groenvold
Journal:  Palliat Med       Date:  2013-12-05       Impact factor: 4.762

6.  Feasibility, acceptability and potential effectiveness of Dignity Therapy for older people in care homes: a phase II randomized controlled trial of a brief palliative care psychotherapy.

Authors:  Sue Hall; Cassie Goddard; Diana Opio; Peter Speck; Irene J Higginson
Journal:  Palliat Med       Date:  2011-08-22       Impact factor: 4.762

7.  A feasibility study of dignity psychotherapy delivered via telemedicine.

Authors:  Steven D Passik; Kenneth L Kirsh; Suzanne Leibee; Lisa S Kaplan; Celia Love; Ellen Napier; Deborah Burton; Robert Sprang
Journal:  Palliat Support Care       Date:  2004-06

8.  Testing the feasibility of the Dignity Therapy interview: adaptation for the Danish culture.

Authors:  Lise J Houmann; Susan Rydahl-Hansen; Harvey M Chochinov; Linda J Kristjanson; Mogens Groenvold
Journal:  BMC Palliat Care       Date:  2010-09-22       Impact factor: 3.234

9.  Efficacy of dignity therapy for depression and anxiety in terminally ill patients: early results of a randomized controlled trial.

Authors:  Miguel Julião; António Barbosa; Fátima Oliveira; Baltazar Nunes; António Vaz Carneiro
Journal:  Palliat Support Care       Date:  2013-03-19

10.  A Phase II randomised controlled trial assessing the feasibility, acceptability and potential effectiveness of dignity therapy for older people in care homes: study protocol.

Authors:  Sue Hall; Harvey Chochinov; Richard Harding; Scott Murray; Alison Richardson; Irene J Higginson
Journal:  BMC Geriatr       Date:  2009-03-24       Impact factor: 3.921

View more
  2 in total

1.  Spirituality During the COVID-19 Pandemic: An Online Creative Arts Intervention With Photocollages for Older Adults in Italy and Israel.

Authors:  Shoshi Keisari; Silvia Piol; Hod Orkibi; Talia Elkarif; Giada Mola; Ines Testoni
Journal:  Front Psychol       Date:  2022-06-16

2.  Interim Analysis of Attrition Rates in Palliative Care Study on Dignity Therapy.

Authors:  Virginia Samuels; Tasha M Schoppee; Amelia Greenlee; Destiny Gordon; Stacey Jean; Valandrea Smith; Tyra Reed; Sheri Kittelson; Tammie Quest; Sean O'Mahony; Josh Hauser; Marvin O Delgado Guay; Michael W Rabow; Linda Emanuel; George Fitchett; George Handzo; Harvey Max Chochinov; Yingwei Yao; Diana J Wilkie
Journal:  Am J Hosp Palliat Care       Date:  2021-02-09       Impact factor: 2.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.